30 results on '"McColgan, Peter"'
Search Results
2. Anti-amphiphysin associated paraneoplastic diencephalitis secondary to a thymic neuroendocrine tumour.
- Author
-
Jesuthasan, Aaron, McColgan, Peter, Sharma, Rohini, and Tai, Yen F.
- Subjects
- *
NEUROENDOCRINE tumors , *PARANEOPLASTIC syndromes , *THYMUS tumors , *STIFF-person syndrome , *ANTI-NMDA receptor encephalitis , *NEUROLOGICAL disorders , *POSITRON emission tomography computed tomography - Abstract
The treatment of choice in paraneoplastic syndromes is often to remove any identifiable underlying tumour, though in our case the improvement was unfortunately transient due to incomplete resection of the tumour. 3 Three-week post-operative In-111 octreotide whole-body SPECT scan, showing increased uptake in the anterior mediastinum in keeping with the residual thymic tumour Discussion Anti-amphiphysin paraneoplastic syndromes are rare, most notably associated with breast and lung carcinoma, although have also been described in isolated melanoma cases [[1]]. Our patient presented with characteristic clinical features of diencephalitis, including a narcoleptic syndrome with cataplectic-like attacks (supported by an undetectable CSF orexin), hypothalamic-pituitary endocrine dysfunction, vertical gaze paresis and associated MRI brain abnormalities. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
3. Neurofilament light-associated connectivity in young-adult Huntington's disease is related to neuronal genes.
- Author
-
McColgan, Peter, Gregory, Sarah, Zeun, Paul, Zarkali, Angeliki, Johnson, Eileanoir B, Parker, Christopher, Fayer, Kate, Lowe, Jessica, Nair, Akshay, Estevez-Fraga, Carlos, Papoutsi, Marina, Zhang, Hui, Scahill, Rachael I, Tabrizi, Sarah J, and Rees, Geraint
- Subjects
- *
HUNTINGTON disease , *CYTOPLASMIC filaments , *PATHOLOGY , *LARGE-scale brain networks , *FUNCTIONAL connectivity - Abstract
Upregulation of functional network connectivity in the presence of structural degeneration is seen in the premanifest stages of Huntington's disease (preHD) 10-15 years from clinical diagnosis. However, whether widespread network connectivity changes are seen in gene carriers much further from onset has yet to be explored. We characterized functional network connectivity throughout the brain and related it to a measure of disease pathology burden (CSF neurofilament light, NfL) and measures of structural connectivity in asymptomatic gene carriers, on average 24 years from onset. We related these measurements to estimates of cortical and subcortical gene expression. We found no overall differences in functional (or structural) connectivity anywhere in the brain comparing control and preHD participants. However, increased functional connectivity, particularly between posterior cortical areas, correlated with increasing CSF NfL level in preHD participants. Using the Allen Human Brain Atlas and expression-weighted cell-type enrichment analysis, we demonstrated that this functional connectivity upregulation occurred in cortical regions associated with regional expression of genes specific to neuronal cells. This relationship was validated using single-nucleus RNAseq data from post-mortem Huntington's disease and control brains showing enrichment of neuronal-specific genes that are differentially expressed in Huntington's disease. Functional brain networks in asymptomatic preHD gene carriers very far from disease onset show evidence of upregulated connectivity correlating with increased disease burden. These changes occur among brain areas that show regional expression of genes specific to neuronal GABAergic and glutamatergic cells. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics.
- Author
-
McColgan, Peter, Helbling, Saskia, Vaculčiaková, Lenka, Pine, Kerrin, Wagstyl, Konrad, Attar, Fakhereh Movahedian, Edwards, Luke, Papoutsi, Marina, Wei, Yongbin, Van den Heuvel, Martijn Pieter, Tabrizi, Sarah J, Rees, Geraint, and Weiskopf, Nikolaus
- Subjects
- *
GENE expression , *CYTOARCHITECTONICS , *HUNTINGTON disease , *DIFFUSION tensor imaging , *MAGNETIC resonance imaging - Abstract
Ultra‐high field MRI across the depth of the cortex has the potential to provide anatomically precise biomarkers and mechanistic insights into neurodegenerative disease like Huntington's disease that show layer‐selective vulnerability. Here we compare multi‐parametric mapping (MPM) measures across cortical depths for a 7T 500 μm whole brain acquisition to (a) layer‐specific cell measures from the von Economo histology atlas, (b) layer‐specific gene expression, using the Allen Human Brain atlas and (c) white matter connections using high‐fidelity diffusion tractography, at a 1.3 mm isotropic voxel resolution, from a 300mT/m Connectom MRI system. We show that R2*, but not R1, across cortical depths is highly correlated with layer‐specific cell number and layer‐specific gene expression. R1‐ and R2*‐weighted connectivity strength of cortico‐striatal and intra‐hemispheric cortical white matter connections was highly correlated with grey matter R1 and R2* across cortical depths. Limitations of the layer‐specific relationships demonstrated are at least in part related to the high cross‐correlations of von Economo atlas cell counts and layer‐specific gene expression across cortical layers. These findings demonstrate the potential and limitations of combining 7T MPMs, gene expression and white matter connections to provide an anatomically precise framework for tracking neurodegenerative disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease.
- Author
-
Zarkali, Angeliki, McColgan, Peter, Leyland, Louise‐Ann, Lees, Andrew J., Weil, Rimona S., and Leyland, Louise-Ann
- Abstract
Background: Visual dysfunction predicts dementia in Parkinson's disease (PD), but whether this translates to structural change is not known. The objectives of this study were to identify longitudinal white matter changes in patients with Parkinson's disease and low visual function and also in those who developed mild cognitive impairment.Methods: We used fixel-based analysis to examine longitudinal white matter change in PD. Diffusion MRI and clinical assessments were performed in 77 patients at baseline (22 low visual function/55 intact vision and 13 PD-mild cognitive impairment/51 normal cognition) and 25 controls and again after 18 months. We compared microstructural changes in fiber density, macrostructural changes in fiber bundle cross-section and combined fiber density and cross-section, across white matter, adjusting for age, sex, and intracranial volume.Results: Patients with PD and visual dysfunction showed worse cognitive performance at follow-up and were more likely to develop mild cognitive impairment compared with those with normal vision (P = 0.008). Parkinson's with poor visual function showed diffuse microstructural and macrostructural changes at baseline, whereas those with mild cognitive impairment showed fewer baseline changes. At follow-up, Parkinson's with low visual function showed widespread macrostructural changes, involving the fronto-occipital fasciculi, external capsules, and middle cerebellar peduncles bilaterally. No longitudinal change was seen in those with mild cognitive impairment at baseline or converters, even when the 2 groups were combined.Conclusion: Parkinson's patients with poor visual function show increased white matter damage over time, providing further evidence for visual function as a marker of imminent cognitive decline. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
6. Concern about Tominersen in Patients with Huntington's Disease.
- Author
-
McColgan, Peter, Tabrizi, Sarah J., and Doody, Rachelle S.
- Subjects
- *
HUNTINGTON disease - Published
- 2024
- Full Text
- View/download PDF
7. Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson's disease.
- Author
-
Zarkali, Angeliki, McColgan, Peter, Leyland, Louise-Ann, Lees, Andrew J., Rees, Geraint, and Weil, Rimona S.
- Subjects
- *
PARKINSON'S disease , *FUNCTIONAL magnetic resonance imaging , *DEMENTIA , *FIBROBLASTS , *IMMUNOGLOBULINS - Abstract
Parkinson's dementia is characterised by changes in perception and thought, and preceded by visual dysfunction, making this a useful surrogate for dementia risk. Structural and functional connectivity changes are seen in humans with Parkinson's disease, but the organisational principles are not known. We used resting-state fMRI and diffusion-weighted imaging to examine changes in structural-functional connectivity coupling in patients with Parkinson's disease, and those at risk of dementia. We identified two organisational gradients to structural-functional connectivity decoupling: anterior-to-posterior and unimodal-to-transmodal, with stronger structural-functional connectivity coupling in anterior, unimodal areas and weakened towards posterior, transmodal regions. Next, we related spatial patterns of decoupling to expression of neurotransmitter receptors. We found that dopaminergic and serotonergic transmission relates to decoupling in Parkinson's overall, but instead, serotonergic, cholinergic and noradrenergic transmission relates to decoupling in patients with visual dysfunction. Our findings provide a framework to explain the specific disorders of consciousness in Parkinson's dementia, and the neurotransmitter systems that underlie these. Zarkali et al. identify two organizational gradients to structural-functional connectivity decoupling in Parkinson's disease and relate spatial patterns of decoupling to the expression of neurotransmitter receptors. This study provides a framework that explains the specific disorders of consciousness in Parkinson's dementia and its related neurotransmitter system. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Differences in network controllability and regional gene expression underlie hallucinations in Parkinson's disease.
- Author
-
Zarkali, Angeliki, McColgan, Peter, Ryten, Mina, Reynolds, Regina, Leyland, Louise-Ann, Lees, Andrew J, Rees, Geraint, and Weil, Rimona S
- Subjects
- *
PARKINSON'S disease , *HALLUCINATIONS , *GENE expression , *GENE regulatory networks , *FUNCTIONAL connectivity , *RNA metabolism , *DIGITAL image processing , *RESEARCH , *NERVOUS system , *RESEARCH methodology , *BRAIN mapping , *MAGNETIC resonance imaging , *RNA , *MEDICAL cooperation , *EVALUATION research , *NEUROPSYCHOLOGICAL tests , *COMPARATIVE studies , *GENES , *GENE expression profiling , *RESEARCH funding , *GENE mapping , *ALGORITHMS , *DISEASE complications - Abstract
Visual hallucinations are common in Parkinson's disease and are associated with poorer prognosis. Imaging studies show white matter loss and functional connectivity changes with Parkinson's visual hallucinations, but the biological factors underlying selective vulnerability of affected parts of the brain network are unknown. Recent models for Parkinson's disease hallucinations suggest they arise due to a shift in the relative effects of different networks. Understanding how structural connectivity affects the interplay between networks will provide important mechanistic insights. To address this, we investigated the structural connectivity changes that accompany visual hallucinations in Parkinson's disease and the organizational and gene expression characteristics of the preferentially affected areas of the network. We performed diffusion-weighted imaging in 100 patients with Parkinson's disease (81 without hallucinations, 19 with visual hallucinations) and 34 healthy age-matched controls. We used network-based statistics to identify changes in structural connectivity in Parkinson's disease patients with hallucinations and performed an analysis of controllability, an emerging technique that allows quantification of the influence a brain region has across the rest of the network. Using these techniques, we identified a subnetwork of reduced connectivity in Parkinson's disease hallucinations. We then used the Allen Institute for Brain Sciences human transcriptome atlas to identify regional gene expression patterns associated with affected areas of the network. Within this network, Parkinson's disease patients with hallucinations showed reduced controllability (less influence over other brain regions), than Parkinson's disease patients without hallucinations and controls. This subnetwork appears to be critical for overall brain integration, as even in controls, nodes with high controllability were more likely to be within the subnetwork. Gene expression analysis of gene modules related to the affected subnetwork revealed that down-weighted genes were most significantly enriched in genes related to mRNA and chromosome metabolic processes (with enrichment in oligodendrocytes) and upweighted genes to protein localization (with enrichment in neuronal cells). Our findings provide insights into how hallucinations are generated, with breakdown of a key structural subnetwork that exerts control across distributed brain regions. Expression of genes related to mRNA metabolism and membrane localization may be implicated, providing potential therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
9. Can neuroimaging predict dementia in Parkinson's disease?
- Author
-
Lanskey, Juliette H, McColgan, Peter, Schrag, Anette E, Acosta-Cabronero, Julio, Rees, Geraint, Morris, Huw R, and Weil, Rimona S
- Subjects
- *
MAGNETIC resonance imaging of the brain , *DIAGNOSIS of dementia , *PARKINSON'S disease , *COGNITION disorders diagnosis , *NEURODEGENERATION , *LEWY body dementia , *PROGNOSIS , *DIAGNOSIS , *NEURAL physiology , *DISEASE progression , *BRAIN , *RESEARCH , *RESEARCH methodology , *MAGNETIC resonance imaging , *COGNITION , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *DEMENTIA , *RESEARCH funding , *NEURORADIOLOGY - Abstract
Dementia in Parkinson's disease affects 50% of patients within 10 years of diagnosis but there is wide variation in severity and timing. Thus, robust neuroimaging prediction of cognitive involvement in Parkinson's disease is important: (i) to identify at-risk individuals for clinical trials of potential new treatments; (ii) to provide reliable prognostic information for individuals and populations; and (iii) to shed light on the pathophysiological processes underpinning Parkinson's disease dementia. To date, neuroimaging has not made major contributions to predicting cognitive involvement in Parkinson's disease. This is perhaps unsurprising considering conventional methods rely on macroscopic measures of topographically distributed neurodegeneration, a relatively late event in Parkinson's dementia. However, new technologies are now emerging that could provide important insights through detection of other potentially relevant processes. For example, novel MRI approaches can quantify magnetic susceptibility as a surrogate for tissue iron content, and increasingly powerful mathematical approaches can characterize the topology of brain networks at the systems level. Here, we present an up-to-date overview of the growing role of neuroimaging in predicting dementia in Parkinson's disease. We discuss the most relevant findings to date, and consider the potential of emerging technologies to detect the earliest signs of cognitive involvement in Parkinson's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes.
- Author
-
McColgan, Peter, Gregory, Sarah, Seunarine, Kiran K., Razi, Adeel, Papoutsi, Marina, Johnson, Eileanoir, Durr, Alexandra, Roos, Raymund A.C., Leavitt, Blair R., Holmans, Peter, Scahill, Rachael I., Clark, Chris A., Rees, Geraint, and Tabrizi, Sarah J.
- Subjects
- *
WHITE matter (Nerve tissue) , *HUNTINGTON disease , *NEUROPLASTICITY , *BRAIN imaging , *GENE expression , *GENETIC transcription - Abstract
Background The earliest white matter changes in Huntington’s disease are seen before disease onset in the premanifest stage around the striatum, within the corpus callosum, and in posterior white matter tracts. While experimental evidence suggests that these changes may be related to abnormal gene transcription, we lack an understanding of the biological processes driving this regional vulnerability. Methods Here, we investigate the relationship between regional transcription in the healthy brain, using the Allen Institute for Brain Science transcriptome atlas, and regional white matter connectivity loss at three time points over 24 months in subjects with premanifest Huntington’s disease relative to control participants. The baseline cohort included 72 premanifest Huntington’s disease participants and 85 healthy control participants. Results We show that loss of corticostriatal, interhemispheric, and intrahemispheric white matter connections at baseline and over 24 months in premanifest Huntington’s disease is associated with gene expression profiles enriched for synaptic genes and metabolic genes. Corticostriatal gene expression profiles are predominately associated with motor, parietal, and occipital regions, while interhemispheric expression profiles are associated with frontotemporal regions. We also show that genes with known abnormal transcription in human Huntington’s disease and animal models are overrepresented in synaptic gene expression profiles, but not in metabolic gene expression profiles. Conclusions These findings suggest a dual mechanism of white matter vulnerability in Huntington’s disease, in which abnormal transcription of synaptic genes and metabolic disturbance not related to transcription may drive white matter loss. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease.
- Author
-
McColgan, Peter, Razi, Adeel, Gregory, Sarah, Seunarine, Kiran K., Durr, Alexandra, A.C. Roos, Raymund, Leavitt, Blair R., Scahill, Rachael I., Clark, Chris A., Langbehn, Doug R., Rees, Geraint, and Tabrizi, Sarah J.
- Abstract
Depression is common in premanifest Huntington's disease (preHD) and results in significant morbidity. We sought to examine how variations in structural and functional brain networks relate to depressive symptoms in premanifest HD and healthy controls. Brain networks were constructed using diffusion tractography (70 preHD and 81 controls) and resting state fMRI (92 preHD and 94 controls) data. A sub-network associated with depression was identified in a data-driven fashion and network-based statistics was used to investigate which specific connections correlated with depression scores. A replication analysis was then performed using data from a separate study. Correlations between depressive symptoms with increased functional connectivity and decreased structural connectivity were seen for connections in the default mode network (DMN) and basal ganglia in preHD. This study reveals specific connections in the DMN and basal ganglia that are associated with depressive symptoms in preHD. Hum Brain Mapp 38:2819-2829, 2017. © 2017 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. White matter predicts functional connectivity in premanifest Huntington's disease.
- Author
-
McColgan, Peter, Gregory, Sarah, Razi, Adeel, Seunarine, Kiran K., Gargouri, Fatma, Durr, Alexandra, Roos, Raymund A. C., Leavitt, Blair R., Scahill, Rachael I., Clark, Chris A., Tabrizi, Sarah J., Rees, Geraint, Coleman, A., Decolongon, J, Fan, M, Petkau, T., Jauffret, C, Justo, D, Lehericy, S, and Nigaud, K
- Subjects
- *
WHITE matter (Nerve tissue) , *HUNTINGTON disease , *BEHAVIOR modification , *NEURODEGENERATION , *FUNCTIONAL magnetic resonance imaging - Abstract
Objectives The distribution of pathology in neurodegenerative disease can be predicted by the organizational characteristics of white matter in healthy brains. However, we have very little evidence for the impact these pathological changes have on brain function. Understanding any such link between structure and function is critical for understanding how underlying brain pathology influences the progressive behavioral changes associated with neurodegeneration. Here, we demonstrate such a link between structure and function in individuals with premanifest Huntington's. Methods Using diffusion tractography and resting state functional magnetic resonance imaging to characterize white matter organization and functional connectivity, we investigate whether characteristic patterns of white matter organization in the healthy human brain shape the changes in functional coupling between brain regions in premanifest Huntington's disease. Results We find changes in functional connectivity in premanifest Huntington's disease that link directly to underlying patterns of white matter organization in healthy brains. Specifically, brain areas with strong structural connectivity show decreases in functional connectivity in premanifest Huntington's disease relative to controls, while regions with weak structural connectivity show increases in functional connectivity. Furthermore, we identify a pattern of dissociation in the strongest functional connections between anterior and posterior brain regions such that anterior functional connectivity increases in strength in premanifest Huntington's disease, while posterior functional connectivity decreases. Interpretation Our findings demonstrate that organizational principles of white matter underlie changes in functional connectivity in premanifest Huntington's disease. Furthermore, we demonstrate functional antero-posterior dissociation that is in keeping with the caudo-rostral gradient of striatal pathology in HD. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.
- Author
-
McColgan, Peter, Seunarine, Kiran K., Razi, Adeel, Cole, James H., Gregory, Sarah, Durr, Alexandra, Roos, Raymund A. C., Stout, Julie C., Landwehrmeyer, Bernhard, Scahill, Rachael I., Clark, Chris A., Rees, Geraint, Tabrizi, Sarah J., and Track-HD Investigators
- Subjects
- *
BASAL ganglia , *BRAIN , *CEREBRAL cortex , *COMPARATIVE studies , *HUNTINGTON disease , *DIGITAL image processing , *LONGITUDINAL method , *MAGNETIC resonance imaging , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *RESEARCH funding , *THALAMUS , *EVALUATION research , *CASE-control method , *NEURAL pathways - Abstract
Huntington's disease can be predicted many years before symptom onset, and thus makes an ideal model for studying the earliest mechanisms of neurodegeneration. Diffuse patterns of structural connectivity loss occur in the basal ganglia and cortex early in the disease. However, the organizational principles that underlie these changes are unclear. By understanding such principles we can gain insight into the link between the cellular pathology caused by mutant huntingtin and its downstream effect at the macroscopic level. The 'rich club' is a pattern of organization established in healthy human brains, where specific hub 'rich club' brain regions are more highly connected to each other than other brain regions. We hypothesized that selective loss of rich club connectivity might represent an organizing principle underlying the distributed pattern of structural connectivity loss seen in Huntington's disease. To test this hypothesis we performed diffusion tractography and graph theoretical analysis in a pseudo-longitudinal study of 50 premanifest and 38 manifest Huntington's disease participants compared with 47 healthy controls. Consistent with our hypothesis we found that structural connectivity loss selectively affected rich club brain regions in premanifest and manifest Huntington's disease participants compared with controls. We found progressive network changes across controls, premanifest Huntington's disease and manifest Huntington's disease characterized by increased network segregation in the premanifest stage and loss of network integration in manifest disease. These regional and whole brain network differences were highly correlated with cognitive and motor deficits suggesting they have pathophysiological relevance. We also observed greater reductions in the connectivity of brain regions that have higher network traffic and lower clustering of neighbouring regions. This provides a potential mechanism that results in a characteristic pattern of structural connectivity loss targeting highly connected brain regions with high network traffic and low clustering of neighbouring regions. Our findings highlight the role of the rich club as a substrate for the structural connectivity loss seen in Huntington's disease and have broader implications for understanding the connection between molecular and systems level pathology in neurodegenerative disease. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review.
- Author
-
Hasan, Nazeeha, McColgan, Peter, Bentley, Paul, Edwards, Robert J., and Sharma, Pankaj
- Subjects
- *
BIOMARKERS , *ETIOLOGY of stroke , *FIBRINOLYSIS , *VASCULAR diseases , *C-reactive protein - Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT Stroke is the largest single cause of disability in the UK. While tests based upon biomarkers have been around for decades, interest in the applications of biomarkers has increased greatly in recent years. Biomarkers released into the bloodstream following a stroke are useful not only for understanding the pathogenesis of stroke, but also play a significant role in the development of personalised medicine. The efficacy of current clinical models and imaging techniques for the diagnosis and prognosis of acute stroke could be improved when used in conjunction with blood biomarkers. While several studies have proposed a number of biomarkers associated with acute stroke in humans, there is conflicting information about the significance of implicated markers, and their clinical relevance is unclear. WHAT THIS STUDY ADDS In an attempt to consolidate the plethora of data in this field, we have conducted a comprehensive systematic review and meta-analysis of proteomic and metabolomic blood biomarkers associated with acute stroke. Our meta-analysis has found eight biomarkers that are significantly associated with the diagnosis and prognosis of acute stroke. Interestingly we also found that CRP, a protein commonly implicated as a strong biomarker of inflammation and stroke, may not have sufficient sensitivity and specificity to be of clinical value, Thus while the biomarkers identified through our study are likely to be biologically informative about the mechanisms of vascular disease, their clinical potential for a blood-based test warrants further investigation. AIMS Identification of biomarkers for stroke will aid our understanding of its aetiology, provide diagnostic and prognostic indicators for patient selection and stratification, and play a significant role in developing personalized medicine. We undertook the largest systematic review conducted to date in an attempt to characterize diagnostic and prognostic biomarkers in acute ischaemic and haemorrhagic stroke and those likely to predict complications following thrombolysis. METHODS A comprehensive literature search was carried out to identify diagnostic and prognostic stroke blood biomarkers. Mean differences (MDs) and 95% confidence intervals (CIs) were calculated for each biomarker. RESULTS We identified a total of 141 relevant studies, interrogating 136 different biomarkers. Three biomarkers (C-reactive protein, P-selectin and homocysteine) significantly differentiated between ischaemic stroke and healthy control subjects. Furthermore, glial fibrillary acidic protein levels were significantly different between haemorrhagic stroke and ischaemic stroke patients (MD 224.58 ng l−1; 95% CI 25.84, 423.32; P= 0.03), high levels of admission glucose were a strong predictor of poor prognosis after ischaemic stroke and symptomatic intracerebral haemorrhage post-thrombolysis, glutamate was found to be an indicator of progressive (unstable) stroke (MD 172.65 µmol l−1, 95% CI 130.54, 214.75; P= 0.00001), D-dimer predicted in-hospital death (MD 0.67 µg ml−1, 95% CI 0.35, 1.00; P= 0.0001), and high fibrinogen levels were associated with poor outcome at 3 months (MD 47.90 mg l−1, 95% CI 14.88, 80.93; P= 0.004) following ischaemic stroke. CONCLUSIONS Few biomarkers currently investigated have meaningful clinical value. Admission glucose may be a strong marker of poor prognosis following acute thrombolytic treatment. However, molecules released in the bloodstream before, during or after stroke may have potential to be translated into sensitive blood-based tests. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
15. Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease.
- Author
-
McColgan, Peter, Evans, Jonathan R., Breen, David P., Mason, Sarah L., Barker, Roger A., and Williams-Gray, Caroline H.
- Abstract
Introduction: Cognitive impairment is common in Parkinson's disease (PD), even in the early stages, and appropriate screening tools are needed. Methods: We investigated the utility of the Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment (MCI) in PD in an incident population-representative cohort (n = 132) and investigated the relationship between performance on this instrument and behavior and quality of life (n = 219). Results: Twenty-two percent met criteria for MCI. Receiver operating curve analysis revealed an area under the curve of 0.81. A cutoff <89 gave a sensitivity of 69% and specificity of 84%. Scores on this instrument were highly correlated with the Parkinson's Disease Cognitive Rating Scale, and there were significant correlations with the Cambridge Behavioral Inventory-Revised and Parkinson's Disease Questionnaire 39. Conclusion: This instrument is a useful screening tool for PD-MCI, and poor performance is significantly related to impaired behavior and quality of life. © 2012 Movement Disorder Society [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
16. Stem Cell Tracking in Human Trials: A Meta-Regression.
- Author
-
McColgan, Peter, Sharma, Pankaj, and Bentley, Paul
- Subjects
- *
STEM cell treatment , *CLINICAL trials , *TREATMENT effectiveness , *STEM cell transplantation , *REGRESSION analysis , *MYOCARDIAL infarction - Abstract
The potential effectiveness of cell therapies is dependent upon homing of transplanted cells to relevant target organs. In this study we firstly characterise the range of methods employed in all human therapeutic-cell studies published to date investigated with cell-tracking. Secondly, we determine factors that predict target-organ cell uptake efficiency by meta-regression. Following a comprehensive literature search, we identified 19 relevant trials, representing 145 patients over the following 7 diseases: myocardial infarction; Chagasic cardiomyopathy; ischemic stroke; traumatic injury of brain or spinal cord; diabetes and cirrhosis. Cell-labelling strategies employed were: 18-fluorodeoxyglucose-PET, 111-indium-SPECT; 99-technetium-SPECT, and iron oxide-MRI. The following methodological parameters were extracted: label type; label dose; labelling efficiency; stability; cell dose; percentage labelled cells; disease type and chronicity; cell purity; cell type; and cell uptake efficiency. Meta-regression techniques were used to identify predictors of cell-labelling efficiency; viability and cell uptake efficiency. These analyses found that labelling efficiency is proportionate to cell dose, while cell viability is lowest with indium and long label incubation times. Uptake efficiency of cells is predicted by stem cell purity (positive association) and cell infusion number (negative association), although these two variables are themselves strongly negatively correlated between studies. In summary the methodological factors associated with enhanced therapeutic-cell homing from both our own analysis, and within-trial comparisons, are: acute (versus chronic) disease, selective stem cells (versus unselected cells), and intra-arterial (versus intravenous) delivery. However, future trials need to keep cell doses and imaging times constant so as to enable meaningful comparisons in uptake efficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
17. The Genetics of Carotid Dissection: Meta-Analysis of a MTHFR/C677T Common Molecular Variant.
- Author
-
McColgan, Peter and Sharma, Pankaj
- Subjects
- *
NUCLEOTIDES , *CAROTID artery diseases , *HOMOCYSTEINE , *SULFUR amino acids , *GENETIC research , *GENOTYPE-environment interaction - Abstract
Background and Purpose: Carotid dissection is a recognized cause of stroke. An association has been reported between carotid dissection and elevated homocysteine levels. Homocysteine levels are partly determined by a thermolibile form of methyltetrahydrofolate reductase (MTHFR) which has a common C677T single nucleotide polymorphism (SNP). We sought to undertake a comprehensive genetic meta-analysis of this SNP and its association with carotid dissection. Methods: All case-control studies evaluating MTHFR/C677T in carotid dissection were identified. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) using both fixed and random effects were determined for both dominant and recessive genetic models. Analyses were also undertaken to compare the effects of the homogenous forms of MTHFR/C677T. Results: Four manuscripts analyzing a total of 420 individuals (183 cases and 237 controls) were identified. The pooled OR for the dominant MTHFR/T677 model was 1.36 (95% CI 0.89–2.08; p = 0.16) while the pooled OR for the recessive TT model was 1.07 (95% CI 0.61–1.89; p = 0.81). To ensure a subtle recessive effect was not being masked by the inclusion of the heterozygous genotype, comparison of the CC and TT genotypes in cases against controls was undertaken but no significant association was observed (OR 0.73; 95% CI 0.38–1.40; p = 0.34). Conclusions: Our data does not support an association between the MTHFR/C677T molecular variant and carotid dissection. As this SNP accounts for the majority of the genetic variance of homocysteine levels, our data suggests that homocysteine is unlikely to play a major role in this condition. Copyright © 2008 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
18. Acute cerebellar ataxia due to Epstein-Barr virus.
- Author
-
Louise McCarthy, Claire, McColgan, Peter, and Martin, Peter
- Published
- 2012
19. Acute cerebellar ataxia due to Epstein-Barr virus.
- Author
-
Louise McCarthy, Claire, McColgan, Peter, and Martin, Peter
- Subjects
- *
DIFFERENTIAL diagnosis , *CEREBELLAR ataxia , *EPSTEIN-Barr virus , *ACUTE diseases , *DIAGNOSIS , *THERAPEUTICS - Abstract
The article presents the case of a17-year-old male who presented with acute cerebellar ataxia. Acute cerebellar ataxia could be caused by vascular, inflammatory, toxic or other reasons. In this case, the development of tonsillitis shortly after ataxia indicated an Epstein-Barr virus (EBV) infection. Serological testing confirmed this hypothesis. Acute cerebellar ataxia is a rare presentation of EBV infection and can occur without the systemic manifestations of EBV.
- Published
- 2012
- Full Text
- View/download PDF
20. Reply: MRI findings of visual system alterations in Parkinson's disease.
- Author
-
Weil, Rimona S., McColgan, Peter, Schrag, Anette E., Warren, Jason D., Crutch, Sebastian J., Lees, Andrew J., and Morris, Huw R.
- Subjects
- *
PARKINSON'S disease , *MAGNETIC resonance imaging , *VISION disorders , *HALLUCINATIONS - Published
- 2017
- Full Text
- View/download PDF
21. Identifying disease‐associated biomarker network features through conditional graphical model.
- Author
-
Xie, Shanghong, Li, Xiang, McColgan, Peter, Scahill, Rachael I., Zeng, Donglin, and Wang, Yuanjia
- Subjects
- *
HUNTINGTON disease , *DISEASE risk factors , *GRAY matter (Nerve tissue) , *SYMPTOMS , *OLIGODENDROGLIA , *DENTAL adhesives - Abstract
Biomarkers are often organized into networks, in which the strengths of network connections vary across subjects depending on subject‐specific covariates (eg, genetic variants). Variation of network connections, as subject‐specific feature variables, has been found to predict disease clinical outcome. In this work, we develop a two‐stage method to estimate biomarker networks that account for heterogeneity among subjects and evaluate network's association with disease clinical outcome. In the first stage, we propose a conditional Gaussian graphical model with mean and precision matrix depending on covariates to obtain covariate‐dependent networks with connection strengths varying across subjects while assuming homogeneous network structure. In the second stage, we evaluate clinical utility of network measures (connection strengths) estimated from the first stage. The second‐stage analysis provides the relative predictive power of between‐region network measures on clinical impairment in the context of regional biomarkers and existing disease risk factors. We assess the performance of proposed method by extensive simulation studies and application to a Huntington's disease (HD) study to investigate the effect of HD causal gene on the rate of change in motor symptom through affecting brain subcortical and cortical gray matter atrophy connections. We show that cortical network connections and subcortical volumes, but not subcortical connections are identified to be predictive of clinical motor function deterioration. We validate these findings in an independent HD study. Lastly, highly similar patterns seen in the gray matter connections and a previous white matter connectivity study suggest a shared biological mechanism for HD and support the hypothesis that white matter loss is a direct result of neuronal loss as opposed to the loss of myelin or dysmyelination. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration.
- Author
-
Estevez-Fraga, Carlos, Altmann, Andre, Parker, Christopher S, Scahill, Rachael I, Costa, Beatrice, Chen, Zhongbo, Manzoni, Claudia, Zarkali, Angeliki, Durr, Alexandra, Roos, Raymund A C, Landwehrmeyer, Bernhard, Leavitt, Blair R, Rees, Geraint, Tabrizi, Sarah J, and McColgan, Peter
- Subjects
- *
HUNTINGTON disease , *GENE expression , *DIFFUSION magnetic resonance imaging , *NEURODEGENERATION , *TOPOGRAPHY , *GENE targeting - Abstract
Cortical cell loss is a core feature of Huntington's disease (HD), beginning many years before clinical motor diagnosis, during the premanifest stage. However, it is unclear how genetic topography relates to cortical cell loss. Here, we explore the biological processes and cell types underlying this relationship and validate these using cell-specific post-mortem data. Eighty premanifest participants on average 15 years from disease onset and 71 controls were included. Using volumetric and diffusion MRI we extracted HD-specific whole brain maps where lower grey matter volume and higher grey matter mean diffusivity, relative to controls, were used as proxies of cortical cell loss. These maps were combined with gene expression data from the Allen Human Brain Atlas (AHBA) to investigate the biological processes relating genetic topography and cortical cell loss. Cortical cell loss was positively correlated with the expression of developmental genes (i.e. higher expression correlated with greater atrophy and increased diffusivity) and negatively correlated with the expression of synaptic and metabolic genes that have been implicated in neurodegeneration. These findings were consistent for diffusion MRI and volumetric HD-specific brain maps. As wild-type huntingtin is known to play a role in neurodevelopment, we explored the association between wild-type huntingtin (HTT) expression and developmental gene expression across the AHBA. Co-expression network analyses in 134 human brains free of neurodegenerative disorders were also performed. HTT expression was correlated with the expression of genes involved in neurodevelopment while co-expression network analyses also revealed that HTT expression was associated with developmental biological processes. Expression weighted cell-type enrichment (EWCE) analyses were used to explore which specific cell types were associated with HD cortical cell loss and these associations were validated using cell specific single nucleus RNAseq (snRNAseq) data from post-mortem HD brains. The developmental transcriptomic profile of cortical cell loss in preHD was enriched in astrocytes and endothelial cells, while the neurodegenerative transcriptomic profile was enriched for neuronal and microglial cells. Astrocyte-specific genes differentially expressed in HD post-mortem brains relative to controls using snRNAseq were enriched in the developmental transcriptomic profile, while neuronal and microglial-specific genes were enriched in the neurodegenerative transcriptomic profile. Our findings suggest that cortical cell loss in preHD may arise from dual pathological processes, emerging as a consequence of neurodevelopmental changes, at the beginning of life, followed by neurodegeneration in adulthood, targeting areas with reduced expression of synaptic and metabolic genes. These events result in age-related cell death across multiple brain cell types. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
- Author
-
Rodrigues, Filipe Brogueira, Byrne, Lauren, McColgan, Peter, Robertson, Nicola, Tabrizi, Sarah J., Leavitt, Blair R., Zetterberg, Henrik, and Wild, Edward J.
- Subjects
- *
CEREBROSPINAL fluid , *HUNTINGTON disease , *DISEASE progression , *TAU proteins , *NEURODEGENERATION , *BIOMARKERS - Abstract
Huntington's disease (HD) is a hereditary neurodegenerative condition with no therapeutic intervention known to alter disease progression, but several trials are ongoing and biomarkers of disease progression are needed. Tau is an axonal protein, often altered in neurodegeneration, and recent studies pointed out its role on HD neuropathology. Our goal was to study whether cerebrospinal fluid (CSF) tau is a biomarker of disease progression in HD. After informed consent, healthy controls, pre-symptomatic and symptomatic gene expansion carriers were recruited from two HD clinics. All participants underwent assessment with the Unified HD Rating Scale '99 (UHDRS). CSF was obtained according to a standardized lumbar puncture protocol. CSF tau was quantified using enzyme-linked immunosorbent assay. Comparisons between two groups were tested using ancova. Pearson's correlation coefficients were calculated for disease progression. Significance level was defined as p < 0.05. Seventy-six participants were included in this cross-sectional multicenter international pilot study. Age-adjusted CSF tau was significantly elevated in gene expansion carriers compared with healthy controls ( p = 0.002). UHDRS total functional capacity was significantly correlated with CSF tau ( r = −0.29, p = 0.004) after adjustment for age, and UHDRS total motor score was significantly correlated with CSF tau after adjustment for age ( r = 0.32, p = 0.002). Several UHDRS cognitive tasks were also significantly correlated with CST total tau after age-adjustment. This study confirms that CSF tau concentrations in HD gene mutation carriers are increased compared with healthy controls and reports for the first time that CSF tau concentration is associated with phenotypic variability in HD. These conclusions strengthen the case for CSF tau as a biomarker in HD. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease.
- Author
-
Rodrigues, Filipe Brogueira, Byrne, Lauren M., McColgan, Peter, Robertson, Nicola, Tabrizi, Sarah J., Zetterberg, Henrik, and Wild, Edward J.
- Subjects
- *
CEREBROSPINAL fluid , *BIOMARKERS , *HUNTINGTON disease , *IMMUNE system , *MICROGLIA , *GENETIC mutation - Abstract
Introduction: Immune system activation is involved in Huntington’s disease (HD) pathogenesis and biomarkers for this process could be relevant to study the disease and characterise the therapeutic response to specific interventions. We aimed to study inflammatory cytokines and microglial markers in the CSF of HD patients. Methods: CSF TNF-α, IL-1β, IL-6, IL-8, YKL-40, chitotriosidase, total tau and neurofilament light chain (NFL) from 23 mutation carriers and 14 healthy controls were assayed. Results: CSF TNF-α and IL-1β were below the limit of detection. Mutation carriers had higher YKL-40 (p = 0.003), chitotriosidase (p = 0.015) and IL-6 (p = 0.041) than controls. YKL-40 significantly correlated with disease stage (p = 0.007), UHDRS total functional capacity score (r = -0.46, p = 0.016), and UHDRS total motor score (r = 0.59, p = 4.5*10−4) after adjustment for age. Conclusion: YKL-40 levels in CSF may, after further study, come to have a role as biomarkers for some aspects of HD. Further investigation is needed to support our exploratory findings. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
25. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson's disease.
- Author
-
Zarkali, Angeliki, Luppi, Andrea I., Stamatakis, Emmanuel A., Reeves, Suzanne, McColgan, Peter, Leyland, Louise-Ann, Lees, Andrew J., and Weil, Rimona S.
- Subjects
- *
PARKINSON'S disease , *HALLUCINATIONS , *NEUROTRANSMITTER receptors , *BRAIN anatomy , *FUNCTIONAL magnetic resonance imaging , *STRUCTURAL dynamics - Abstract
Hallucinations are a core feature of psychosis and common in Parkinson's. Their transient, unexpected nature suggests a change in dynamic brain states, but underlying causes are unknown. Here, we examine temporal dynamics and underlying structural connectivity in Parkinson's-hallucinations using a combination of functional and structural MRI, network control theory, neurotransmitter density and genetic analyses. We show that Parkinson's-hallucinators spent more time in a predominantly Segregated functional state with fewer between-state transitions. The transition from integrated-to-segregated state had lower energy cost in Parkinson's-hallucinators; and was therefore potentially preferable. The regional energy needed for this transition was correlated with regional neurotransmitter density and gene expression for serotoninergic, GABAergic, noradrenergic and cholinergic, but not dopaminergic, receptors. We show how the combination of neurochemistry and brain structure jointly shape functional brain dynamics leading to hallucinations and highlight potential therapeutic targets by linking these changes to neurotransmitter systems involved in early sensory and complex visual processing. The examination of temporal dynamics in Parkinson's-hallucinations reveals that the combination of neurochemistry and brain structure jointly shape functional brain dynamics leading to hallucinations. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders.
- Author
-
Rittman, Timothy, Ghosh, Boyd C., McColgan, Peter, Breen, David P., Evans, Jonathan, Williams-Gray, Caroline H., Barker, Roger A., and Rowe, James B.
- Subjects
- *
PARKINSONIAN disorders , *COGNITION , *DIFFERENTIAL diagnosis , *LONGITUDINAL method , *NEURODEGENERATION , *SENSITIVITY analysis , *DIAGNOSIS - Abstract
Objective Differentiating idiopathic Parkinson's disease from atypical parkinsonian syndromes is challenging, especially in the early stages. We assessed whether the Revised Addenbrooke's Cognitive Examination (ACE-R) could differentiate between parkinsonian syndromes and reflect longitudinal changes in cognition in these disorders. Methods The ACE-R was administered at baseline and after approximately 18 months to 135 patients with parkinsonian disorders: 86 with idiopathic Parkinson's disease (PD), 30 with progressive supranuclear palsy (PSP), 19 with corticobasal degeneration (CBD). We assessed differences between groups for ACE-R, ACE-R subscores and Mini Mental State Examination (MMSE) scores at baseline (analyses of variance, receiver operating characteristics curves), and the interaction between diagnosis and change in ACE-R scores between visits (analyses of variance). Results The ACE-R verbal fluency subscore distinguished between PSP and PD with a high sensitivity (0.92) and specificity (0.87); total ACE-R score and the visuospatial subscore were less specific (0.87 and 0.84 respectively) and sensitive (0.70 and 0.73). Significant group level differences were found between PD and PSP for MMSE and ACE-R (total score and subscores for attention and concentration, fluency, language, and visuospatial function), and between PD and CBD for the ACE-R visuospatial subscore. Performance worsened between visits for ACE-R score in PD ( p=0.001) and CBD (p=0.001); visuospatial subscore in PD ( p=0.003), PSP (p=0.022) and CBD (p=0.0002); and MMSE in CBD (p=0.004). Conclusions We propose the ACE-R, particularly the verbal fluency subscore, as a valuable contributor to the differential diagnosis of parkinsonian syndromes in the correct clinical context. The ACE-R may reflect disease progression in PD and CBD. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
27. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.
- Author
-
Thomas, George E C, Zarkali, Angeliki, Ryten, Mina, Shmueli, Karin, Gil-Martinez, Ana Luisa, Leyland, Louise-Ann, McColgan, Peter, Acosta-Cabronero, Julio, Lees, Andrew J, Weil, Rimona S, and Martinez, Ana Luisa Gil
- Subjects
- *
PARKINSON'S disease , *PARTIAL least squares regression , *GENE expression , *IRON , *GENE expression profiling , *IRON metabolism , *BRAIN , *COMPUTERS in medicine , *RESEARCH , *RESEARCH methodology , *MAGNETIC resonance imaging , *MEDICAL cooperation , *EVALUATION research , *OXIDATIVE stress , *DIAGNOSTIC imaging , *COMPARATIVE studies , *RESEARCH funding , *NEURODEGENERATION , *NEURORADIOLOGY ,BRAIN metabolism - Abstract
The mechanisms responsible for the selective vulnerability of specific neuronal populations in Parkinson's disease are poorly understood. Oxidative stress secondary to brain iron accumulation is one postulated mechanism. We measured iron deposition in 180 cortical regions of 96 patients with Parkinson's disease and 35 control subjects using quantitative susceptibility mapping. We estimated the expression of 15 745 genes in the same regions using transcriptomic data from the Allen Human Brain Atlas. Using partial least squares regression, we then identified the profile of gene transcription in the healthy brain that underlies increased cortical iron in patients with Parkinson's disease relative to controls. Applying gene ontological tools, we investigated the biological processes and cell types associated with this transcriptomic profile and identified the sets of genes with spatial expression profiles in control brains that correlated significantly with the spatial pattern of cortical iron deposition in Parkinson's disease. Gene ontological analyses revealed that these genes were enriched for biological processes relating to heavy metal detoxification, synaptic function and nervous system development and were predominantly expressed in astrocytes and glutamatergic neurons. Furthermore, we demonstrated that the genes differentially expressed in Parkinson's disease are associated with the pattern of cortical expression identified in this study. Our findings provide mechanistic insights into regional selective vulnerabilities in Parkinson's disease, particularly the processes involving iron accumulation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
- Author
-
Scahill, Rachael I, Zeun, Paul, Osborne-Crowley, Katherine, Johnson, Eileanoir B, Gregory, Sarah, Parker, Christopher, Lowe, Jessica, Nair, Akshay, O'Callaghan, Claire, Langley, Christelle, Papoutsi, Marina, McColgan, Peter, Estevez-Fraga, Carlos, Fayer, Kate, Wellington, Henny, Rodrigues, Filipe B, Byrne, Lauren M, Heselgrave, Amanda, Hyare, Harpreet, and Sampaio, Cristina
- Subjects
- *
BRAIN , *DISEASE progression , *RESEARCH , *NERVE tissue proteins , *CROSS-sectional method , *BASAL ganglia , *RESEARCH methodology , *MAGNETIC resonance imaging , *EVALUATION research , *MEDICAL cooperation , *NEUROPSYCHOLOGICAL tests , *GENETIC carriers , *COMPARATIVE studies , *HUNTINGTON disease , *NEURORADIOLOGY - Abstract
Background: Disease-modifying treatments are in development for Huntington's disease; crucial to their success is to identify a timepoint in a patient's life when there is a measurable biomarker of early neurodegeneration while clinical function is still intact. We aimed to identify this timepoint in a novel cohort of young adult premanifest Huntington's disease gene carriers (preHD) far from predicted clinical symptom onset.Methods: We did the Huntington's disease Young Adult Study (HD-YAS) in the UK. We recruited young adults with preHD and controls matched for age, education, and sex to ensure each group had at least 60 participants with imaging data, accounting for scan fails. Controls either had a family history of Huntington's disease but a negative genetic test, or no known family history of Huntington's disease. All participants underwent detailed neuropsychiatric and cognitive assessments, including tests from the Cambridge Neuropsychological Test Automated Battery and a battery assessing emotion, motivation, impulsivity and social cognition (EMOTICOM). Imaging (done for all participants without contraindications) included volumetric MRI, diffusion imaging, and multiparametric mapping. Biofluid markers of neuronal health were examined using blood and CSF collection. We did a cross-sectional analysis using general least-squares linear models to assess group differences and associations with age and CAG length, relating to predicted years to clinical onset. Results were corrected for multiple comparisons using the false discovery rate (FDR), with FDR <0·05 deemed a significant result.Findings: Data were obtained between Aug 2, 2017, and April 25, 2019. We recruited 64 young adults with preHD and 67 controls. Mean ages of participants were 29·0 years (SD 5·6) and 29·1 years (5·7) in the preHD and control groups, respectively. We noted no significant evidence of cognitive or psychiatric impairment in preHD participants 23·6 years (SD 5·8) from predicted onset (FDR 0·22-0·87 for cognitive measures, 0·31-0·91 for neuropsychiatric measures). The preHD cohort had slightly smaller putamen volumes (FDR=0·03), but this did not appear to be closely related to predicted years to onset (FDR=0·54). There were no group differences in other brain imaging measures (FDR >0·16). CSF neurofilament light protein (NfL), plasma NfL, and CSF YKL-40 were elevated in this far-from-onset preHD cohort compared with controls (FDR<0·0001, =0·01, and =0·03, respectively). CSF NfL elevations were more likely in individuals closer to expected clinical onset (FDR <0·0001).Interpretation: We report normal brain function yet a rise in sensitive measures of neurodegeneration in a preHD cohort approximately 24 years from predicted clinical onset. CSF NfL appears to be a more sensitive measure than plasma NfL to monitor disease progression. This preHD cohort is one of the earliest yet studied, and our findings could be used to inform decisions about when to initiate a potential future intervention to delay or prevent further neurodegeneration while function is intact.Funding: Wellcome Trust, CHDI Foundation. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
29. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
- Author
-
Gargouri, Fatma, Messé, Arnaud, Perlbarg, Vincent, Valabregue, Romain, McColgan, Peter, Yahia ‐ Cherif, Lydia, Fernandez ‐ Vidal, Sara, Ben Hamida, Ahmed, Benali, Habib, Tabrizi, Sarah, Durr, Alexandra, and Lehéricy, Stéphane
- Abstract
Huntington's disease (HD) is a genetic neurological disorder resulting in cognitive and motor impairments. We evaluated the longitudinal changes of functional connectivity in sensorimotor, associative and limbic cortico-basal ganglia networks. We acquired structural MRI and resting-state fMRI in three visits one year apart, in 18 adult HD patients, 24 asymptomatic mutation carriers (preHD) and 18 gender- and age-matched healthy volunteers from the TRACK-HD study. We inferred topological changes in functional connectivity between 182 regions within cortico-basal ganglia networks using graph theory measures. We found significant differences for global graph theory measures in HD but not in preHD. The average shortest path length ( L) decreased, which indicated a change toward the random network topology. HD patients also demonstrated increases in degree k, reduced betweeness centrality bc and reduced clustering C. Changes predominated in the sensorimotor network for bc and C and were observed in all circuits for k. Hubs were reduced in preHD and no longer detectable in HD in the sensorimotor and associative networks. Changes in graph theory metrics ( L, k, C and bc) correlated with four clinical and cognitive measures (symbol digit modalities test, Stroop, Burden and UHDRS). There were no changes in graph theory metrics across sessions, which suggests that these measures are not reliable biomarkers of longitudinal changes in HD. preHD is characterized by progressive decreasing hub organization, and these changes aggravate in HD patients with changes in local metrics. HD is characterized by progressive changes in global network interconnectivity, whose network topology becomes more random over time. Hum Brain Mapp 37:4112-4128, 2016. © 2016 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
30. Basal ganglia-cortical structural connectivity in Huntington's disease.
- Author
-
Novak, Marianne J.U., Seunarine, Kiran K., Gibbard, Clare R., McColgan, Peter, Draganski, Bogdan, Friston, Karl, Clark, Chris A., and Tabrizi, Sarah J.
- Abstract
Huntington's disease is an incurable neurodegenerative disease caused by inheritance of an expanded cytosine-adenine-guanine (CAG) trinucleotide repeat within the Huntingtin gene. Extensive volume loss and altered diffusion metrics in the basal ganglia, cortex and white matter are seen when patients with Huntington's disease (HD) undergo structural imaging, suggesting that changes in basal ganglia-cortical structural connectivity occur. The aims of this study were to characterise altered patterns of basal ganglia-cortical structural connectivity with high anatomical precision in premanifest and early manifest HD, and to identify associations between structural connectivity and genetic or clinical markers of HD. 3-Tesla diffusion tensor magnetic resonance images were acquired from 14 early manifest HD subjects, 17 premanifest HD subjects and 18 controls. Voxel-based analyses of probabilistic tractography were used to quantify basal ganglia-cortical structural connections. Canonical variate analysis was used to demonstrate disease-associated patterns of altered connectivity and to test for associations between connectivity and genetic and clinical markers of HD; this is the first study in which such analyses have been used. Widespread changes were seen in basal ganglia-cortical structural connectivity in early manifest HD subjects; this has relevance for development of therapies targeting the striatum. Premanifest HD subjects had a pattern of connectivity more similar to that of controls, suggesting progressive change in connections over time. Associations between structural connectivity patterns and motor and cognitive markers of disease severity were present in early manifest subjects. Our data suggest the clinical phenotype in manifest HD may be at least partly a result of altered connectivity. Hum Brain Mapp 36:1728-1740, 2015. © 2015 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.